Larvol Delta - Moleculin-Announces-Positive-Interim-Data-in-Annamycin-Clinical-Trials-MB106-AML-Trial-Complete-Response-CR-Rate-of-38-and-MB107-STS-Lung-Mets-Trial-Median-Phase-1B-Extended-Overall-Survival-of-11-Months

WP1066 - Moleculin, WPD Pharma

WP1122 - Moleculin, CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/moleculin-announces-positive-interim-data-in-annamycin-clinical-trials-mb-106-aml-trial-complete-response-cr-rate-of-38-and-mb-107-sts-lung-mets-trial-median-phase-1b-extended-overall-survival-of-11-months-301985417.html

Nov 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next